Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation

Journal of Hematology and Oncology

Volumn 2, Issue , 2009, Pages

  Mcguirk, Joseph ^a,e   Hao, Gang ^c   Hou, Weijian ^a   Abhyankar, Sunil ^a   Williams, Casey ^a   Yan, Weisi ^c   Yuan, Jianda ^d   Guan, Xiuqin ^b   Belt, Robert ^a   Dejarnette, Shaun ^a   Wieman, Jeffery ^a   Yan, Ying ^a,b  

^a St Luke's College   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A4; ARYLDIALKYLPHOSPHATASE; BUSULFAN; CLUSTERIN; COMPLEMENT COMPONENT C4; CYTARABINE; GLYCOPROTEIN; HAPTOGLOBIN; METHOTREXATE; PREDNISONE; SEROTRANSFERRIN; SEX HORMONE BINDING GLOBULIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC ALPHA GLYCOPROTEIN; HP PROTEIN, HUMAN; PLASMA PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GRAFT VERSUS HOST REACTION; HEART FAILURE; HUMAN; IMMUNOBLOTTING; INCIDENCE; MALE; MASS SPECTROMETRY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; TWO DIMENSIONAL GEL ELECTROPHORESIS; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; BLOOD; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PHYSIOLOGY; TANDEM MASS SPECTROMETRY;

ADULT; AMINO ACID SEQUENCE; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HAPTOGLOBINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 67651156244     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-2-17     Document Type: Article

References (42)

1. Copelan EA: Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Leisenring WM, Martin PJ, Petersdorf EW, Regan AE, Aboulhosn N, Stern JM, Aker SN, Salazar RC, McDonald GB: An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 2006, 108 (2):749-755.
3. Deeg HJ, Antin JH: The Clinical Spectrum of Acute Graft-Versus-Host Disease. Semin Hematol 2006, 43:24-31.
4. Vogelsang GB, Hess AD, Berkman AW, Tutschka PJ, Farmer ER, Converse PJ, Santos GW: An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med 1985, 313:645-650.
5. Dickinson AM, Sviland L, Wang XN, Jackson G, Taylor PR, Dunn A, Proctor SJ: Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model. Transplantation 1998, 66:857-863.
6. Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H: Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 1992, 327:1613-1617.
7. Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM: T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Transplantation 2000, 70:488-493.
8. Dickinson AM, Holler E: Polymorphisms of cytokine and innate immunity genes and GVHD. Best Prac & Res Clin Haematol 2008, 21:149-164.
9. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA Jr, Latouche A, Devergie A, Esperou H, Ribaud P, Socie G, Zago MA, Gluckman E: Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002, 100:3908-3918.
10. Cullup H, Dickinson AM, Cavet J, Jackson GH, Middleton PG: Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2003, 122 (5):778-87.
11. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA: Relation of an interleukin-10 promoter polymorphism to graft-versus-Host disease and survival after hematopoietic-Cell transplantation. N Engl J Med 2003, 349:2201-10.
12. Behar E, Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC: Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996, 334 (5):286-91.
13. Cavet J, Dickinson AM, Norden J, Taylor PRA, Jackson GH, Middleton PG: Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001, 98:1594-1600.
14. Mateos-Caceres PJ, Garcia-Mendez A, Lopez Farre A, Macaya C, Nunez A, Gomez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andres R, Granizo JJ, Farre J, Rico LA: Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004, 44 (8):1578-83.
15. Hershko AY, Naparstek Y: Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 2006, 5 (4):230-233.
16. Albitar M, Potts SJ, Giles FJ, O'Brien S, Keating M, Thomas D, Clarke C, Jilani I, Aguilar C, Estey E, Kantarjian H: Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer 2006, 106 (7):1587-1594.
17. Hudelist G, Singer CF, Pischinger KI, Kaserer K, Manavi M, Kubista E, Czerwenka KF: Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium. Proteomics 2006, 6 (6):1989-2002.
18. Wang H, Clouthier SG, Galchev V, Misek DE, Duffner U, Min CK, Zhao R, Tra J, Omenn GS, Ferrara JL, Hanash SM: Intact-proteinbased high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 2005, 4 (5):618-625.
19. Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM: Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004, 104 (2):340-349.
20. Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JLM: A biomarker panel for acute graft-versus-host disease. Blood 2009, 113:273-278.
21. Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zürbig P, Kellmann M, Ganser A: Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 2007, 109:5511-5519.
22. Hori T, Naishiro Y, Sohma H, Suzuki N, Hatakeyama N, Yamamoto M, Sonoda T, Mizue Y, Imai K, Tsutsumi H, Kokai Y: CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease. Blood 2008, 111:4403-4412.
23. Westereier R: Electrophoresis in practice. In Part II WILEY-VCH; 2001:123-286.
24. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schomig A, Kastrati A: Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002, 48 (9):1377-82.
25. Beutler E, Gelbart T, Lee P: haptoglobin polymorphism and iron homeostasis. Clin Chem 2002, 48:2232-2235.
26. Sadrzadeh SMH, Bozorgmehr J: Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004, 121 Suppl:S97-S104.
27. Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleine D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga E, Hitt B, Barrett AJ, Rosenblattc K, Childs RW: Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Expe Hematol 2006, 34:796-801.
28. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994, 15:74-80.
29. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
30. Wang Y, Kinzie E, Berger FG, Lim SK, Baumann H: Haptoglobin, an inflammation-inducible plasma protein. Redox Rep 2001, 6:379-385.
31. Harvey SB, Zhang Y, Wilson-Grady J, Monkkonen T, Nelsestuen JL, Kasthuri JS, Verneris MR, Lund TC, Ely EW, GR Bernard, Zeisler H, Homoncik M, Jilma B, Swan T, Kellogg TA: O-Glycoside Biomarker of Apolipoprotein C3: Responsiveness to Obesity, Bariatric Surgery, and Therapy with Metformin, to Chronic or Severe Liver Disease and to Mortality in Severe Sepsis and Graft vs Host Disease. J Proteome Res 2009, 8:603-612.
32. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, Holler E, Iacobelli M, Kentouche K, Lämmle B, Moake JL, Richardson P, Socié G, Zeigler Z, Niederwieser D, Barbui T: Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007, 92:95-100.
33. Langlois MR, Delanghe JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996, 42 (10):1589-1600.
34. Wicher KB, Fries E: Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein. PNAS 2004, 101:14390-14395.
35. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J: Structure and assembly of haptoglobin polymers by electron microscopy. J Mol Biol 1984, 174:343-368.
36. Lange V: Haptoglobin polymorphism: not only a genetic marker. Anthropol Anz 1992, 50:281-302.
37. Gutteridge JM: The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987, 917:219-223.
38. Gogishvili AV, Kavtaradze VG, Mamaladze GT: Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct. Kardiologiia 1985, 25:55-58.
39. Chapelle JP, Albert A, Smeets JP, Heusghem C, Kulbertus HE: Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982, 307:457-463.
40. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, et al.: Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000, 343:969-70.
41. Rantapãã Dahlqvist S, Fröhlander N: Haptoglobin groups and rheumatoid arthritis. Hum Hered 1985, 35:207-11.
42. Rantapãã, Dahlqvist, Beckman G, Beckman L: Serum protein markers in systemic lupus erythematosus. Hum Hered 1988, 38:44-7.